Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garraway

Showing results (421-430 of 549) with videos related to

Pageof 55
Sort By:
Nature Communications|September 27, 2019
Metabolomic adaptations and correlates of survival to immune checkpoint blockadeHaoxin Li, Kevin Bullock, Carino Gurjao, et al.
Science (New York, N.Y.)|February 26, 2016
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cellsGregory V Kryukov, Frederick H Wilson, Jason R Ruth, et al.
Nature|March 25, 2011
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onsetCraig J Ceol, Yariv Houvras, Judit Jane-Valbuena, et al.
Neuro-Oncology|January 14, 2017
A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomasYu Sun, John A Alberta, Catherine Pilarz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 15, 2025
Association of HOXB13 G84E With Prostate Cancer Among 592,158 MenTaylor B Crawford, Tyler Nelson, Roshan Karunamuni, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patientsTaylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
Genome Medicine|April 20, 2017
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burdenZachary R Chalmers, Caitlin F Connelly, David Fabrizio, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2014
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancerVivian Wai Yan Lui, Noah D Peyser, Patrick Kwok-Shing Ng, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated RadiationJonathan Tward, Lauren Lenz, Darl D Flake, et al.
The Prostate|January 27, 2022
Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samplesElizabeth H Stover, Coyin Oh, Paula Keskula, et al.
Pageof 55

Showing results (421-430 of 549) with videos related to

Sort By:
Pageof 55
Nature Communications|September 27, 2019
Metabolomic adaptations and correlates of survival to immune checkpoint blockadeHaoxin Li, Kevin Bullock, Carino Gurjao, et al.
Science (New York, N.Y.)|February 26, 2016
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cellsGregory V Kryukov, Frederick H Wilson, Jason R Ruth, et al.
Nature|March 25, 2011
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onsetCraig J Ceol, Yariv Houvras, Judit Jane-Valbuena, et al.
Neuro-Oncology|January 14, 2017
A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomasYu Sun, John A Alberta, Catherine Pilarz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 15, 2025
Association of HOXB13 G84E With Prostate Cancer Among 592,158 MenTaylor B Crawford, Tyler Nelson, Roshan Karunamuni, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patientsTaylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
Genome Medicine|April 20, 2017
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burdenZachary R Chalmers, Caitlin F Connelly, David Fabrizio, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2014
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancerVivian Wai Yan Lui, Noah D Peyser, Patrick Kwok-Shing Ng, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated RadiationJonathan Tward, Lauren Lenz, Darl D Flake, et al.
The Prostate|January 27, 2022
Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samplesElizabeth H Stover, Coyin Oh, Paula Keskula, et al.
Pageof 55